US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Moderna, Inc. - Common Stock (NQ:MRNA)

221.72 -1.04 (-0.47%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
3 Healthcare Stocks That Concern Us
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
News headline image
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy? ↗
It has been a volatile year for the biotech. 
Via The Motley Fool
News headline image
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. ↗
It was a head-turning headline. Here's why the market was buzzing. 
Via The Motley Fool
Topics ETFs
News headline image
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027? ↗
Sandisk is changing its business model to reduce its cyclicality. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going ↗
Momentum is only half the battle. Their underlying companies still need to justify the continued bullishness of their stocks. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after capital-intensive growth equities experienced sharp sell-offs as elevated bond yields r... 
Via StockStory
Topics Bonds Economy
S&P 500 Top Movers: Today's Gainers and Losers ↗
Via Chartmill
Topics Stocks
Most-Active S&P 500 Stocks in Oct. 16, 2026 US Session ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers Today: HONA Tops Gainers, TWLO Tops Decliners ↗
Via Chartmill
Topics Stocks
S&P 500 Gap Downs on October 16: MRNA, TWLO and COHR Lead Declines ↗
Via Chartmill
Topics Stocks
News headline image
Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy? ↗
This stock has soared more than 600% this year. 
Via The Motley Fool
Topics Artificial Intelligence
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
News headline image
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
From Biotech Insider
Via GlobeNewswire
News headline image
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just cleared a key FDA hurdle with an expanding oncology pipeline behind it. 
Via The Motley Fool
Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick? ↗
Is bigger always better? Not necessarily. 
Via The Motley Fool
News headline image
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys? ↗
Forget the "Magnificent Seven" in favor of the "Tremendous Three"? 
Via The Motley Fool
News headline image
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell? ↗
After a few years of stagnation, this stock is soaring. 
Via The Motley Fool
News headline image
Why Moderna Stock Surged Today ↗
The biotech could play a significant role in a national effort to combat cancer. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street ↗
Have Moderna’s shares risen too much, too fast? 
Via The Motley Fool
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Friday. ↗
Via Chartmill
News headline image
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026? ↗
Axsome is posting 65% revenue growth but burning cash, while Moderna's vaccine market is cooling yet its oncology pipeline carries transformative potential. 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Is Now the Time to Cash Out of the S&P 500's Top 3 Stocks of 2026? ↗
These stocks have all soared more than 350% this year. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
Tuesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >